Cargando…
Clinical implications of six inflammatory biomarkers as prognostic indicators in Ewing sarcoma
Cancer-related systemic inflammation responses have been correlated with cancer development and progression. The prognostic significance of several inflammatory indicators, including neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio (PLR), Glasgow Prognostic Score (GPS), C-reactive protei...
Autores principales: | Li, Yong-Jiang, Yang, Xi, Zhang, Wen-Biao, Yi, Cheng, Wang, Feng, Li, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628701/ https://www.ncbi.nlm.nih.gov/pubmed/29033609 http://dx.doi.org/10.2147/CMAR.S146827 |
Ejemplares similares
-
The clinical use of biomarkers as prognostic factors in Ewing sarcoma
por: van Maldegem, Annmeik M, et al.
Publicado: (2012) -
CCT6A, a novel prognostic biomarker for Ewing sarcoma
por: Jiang, Jie, et al.
Publicado: (2021) -
Prognostic implication of cuproptosis related genes associates with immunity in Ewing's sarcoma
por: Li, Qingbo, et al.
Publicado: (2023) -
Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma
por: Evola, Francesco R., et al.
Publicado: (2017) -
Novel prognostic biomarkers, METTL14 and YTHDF2, associated with RNA methylation in Ewing’s sarcoma
por: Jiang, Jie, et al.
Publicado: (2022)